Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.
Department of Ophthalmology, Guthrie Clinic, Sayre, Pennsylvania, U.S.A.
Ophthalmic Plast Reconstr Surg. 2019 May/Jun;35(3):272-280. doi: 10.1097/IOP.0000000000001231.
To describe risk factors, clinical parameters, treatment, and prognosis for patients with septic cavernous sinus thrombosis presenting with orbital cellulitis.
Retrospective case series of 6 patients identified with septic cavernous sinus thrombosis and orbital cellulitis confirmed by magnetic resonance imaging at a tertiary care center from January 1980 to December 2016. Medical records were reviewed for demographics, risk factors, symptoms, etiology, radiographic diagnosis, complications, treatments, and outcomes. In addition, a literature review was performed from 2005 to 2018, and 119 cases of septic cavernous sinus thrombosis confirmed by imaging were included for aggregate comparison. This study adheres to the tenets of the Declaration of Helsinki, and institutional review board approval was obtained.
All 6 cases presented with headache, fever, ocular motility deficit, periorbital edema, and proptosis. The primary source of infection included sinusitis (n = 4) and bacteremia (n = 2). Identified microorganisms included methicillin resistant Staphylococcus aureus (n = 3) and Streptococcus anginosus (n = 1). All cases were treated with broad-spectrum intravenous antibiotics and anticoagulation, and one case underwent endoscopic sinus surgery. The mean time between initial presentation to diagnosis of cavernous sinus thrombosis was 2.8 days, and the average length of hospital admission was 21 days. The mortality rate was 0%, but 4 cases were discharged with neurological deficits including vision loss (n = 1) and ocular motility disturbance (n = 3). Literature review produced an additional 119 cases.
Early diagnostic imaging with contrast-enhanced CT or MRI should be initiated in patients with risk factors and ocular symptoms concerning for cavernous sinus thrombosis. Treatment entails early administration of broad-spectrum intravenous antibiotics, anticoagulation, and surgical drainage when applicable.
描述以眶蜂窝织炎为表现的感染性海绵窦血栓形成患者的危险因素、临床参数、治疗方法和预后。
回顾性病例系列研究,在一家三级保健中心,我们从 1980 年 1 月至 2016 年 12 月,使用磁共振成像(MRI)对 6 例经证实为感染性海绵窦血栓形成和眶蜂窝织炎的患者进行了研究。我们对患者的人口统计学、危险因素、症状、病因、放射学诊断、并发症、治疗方法和结果进行了病历回顾。此外,我们还对 2005 年至 2018 年的文献进行了综述,共纳入了 119 例经影像学证实的感染性海绵窦血栓形成病例进行汇总比较。本研究符合《赫尔辛基宣言》的原则,并获得了机构审查委员会的批准。
所有 6 例患者均有头痛、发热、眼球运动障碍、眶周水肿和眼球突出。感染的主要来源包括鼻窦炎(n=4)和菌血症(n=2)。鉴定出的微生物包括耐甲氧西林金黄色葡萄球菌(n=3)和咽峡炎链球菌(n=1)。所有病例均接受了广谱静脉内抗生素和抗凝治疗,1 例患者接受了鼻内镜手术。从初次就诊到诊断为海绵窦血栓形成的平均时间为 2.8 天,平均住院时间为 21 天。死亡率为 0%,但有 4 例患者出院时仍存在神经功能缺损,包括视力丧失(n=1)和眼球运动障碍(n=3)。文献综述还纳入了另外 119 例病例。
对于有发生海绵窦血栓形成风险且伴有眼部症状的患者,应尽早行增强 CT 或 MRI 诊断。治疗包括早期给予广谱静脉内抗生素、抗凝和有适应证时进行手术引流。